Pharmaceutical companies are increasingly integrating wearable continuous monitoring devices into late-stage clinical trials. Real-time telemetry allows researchers to capture granular physiological data without requiring frequent clinical visits.
Data Fidelity and Cost Efficiency
Trial dropout rates have decreased by 18% in studies utilizing continuous telemetry. Regulatory agencies are issuing standardized guidance on real-world evidence data collection to validate these methods.